Hualan Biological Vaccine Inc. (SHE:301207)
China flag China · Delayed Price · Currency is CNY
14.05
-0.15 (-1.06%)
Nov 17, 2026, 3:04 PM CST

Hualan Biological Vaccine Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
8,36011,08510,41816,68017,832-
Market Cap Growth
-44.64%6.40%-37.54%-6.46%--
Enterprise Value
5,1018,0098,18014,34615,905-
Last Close Price
14.0517.7816.0324.6526.19-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
180.7960.6050.6919.4034.32-
Forward PE
39.037.759.8615.2217.00-
PS Ratio
11.999.229.246.929.77-
PB Ratio
1.621.941.732.663.24-
P/TBV Ratio
1.631.951.742.673.26-
P/FCF Ratio
22.4831.9125.0220.2190.98-
P/OCF Ratio
21.3031.0422.2618.7861.78-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
EV/Sales Ratio
7.316.667.255.958.71-
EV/EBITDA Ratio
61.0134.6234.8114.0324.91-
EV/EBIT Ratio
-88.7386.4316.2731.55-
EV/FCF Ratio
13.7223.0519.6417.3881.14-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Debt / Equity Ratio
--0.050.050.060.18
Debt / EBITDA Ratio
--1.280.290.470.68
Debt / FCF Ratio
--0.720.361.53-
Net Debt / Equity Ratio
-0.63-0.49-0.49-0.37-0.34-0.16
Net Debt / EBITDA Ratio
-38.97-12.04-12.45-2.26-2.90-0.61
Net Debt / FCF Ratio
-8.76-8.02-7.03-2.80-9.436.82
Asset Turnover
0.100.170.140.320.320.45
Inventory Turnover
0.791.681.502.242.694.64
Quick Ratio
3.843.703.192.732.571.43
Current Ratio
4.643.923.403.102.731.51
Return on Equity (ROE)
0.85%3.12%3.35%14.63%12.51%24.86%
Return on Assets (ROA)
-0.54%0.78%0.76%7.32%5.43%10.28%
Return on Invested Capital (ROIC)
-2.82%2.93%2.58%19.83%14.81%30.53%
Return on Capital Employed (ROCE)
-1.10%1.60%1.60%14.00%9.10%23.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Earnings Yield
0.55%1.65%1.97%5.16%2.91%-
FCF Yield
4.45%3.13%4.00%4.95%1.10%-
Dividend Yield
11.39%7.51%1.14%2.16%0.67%-
Payout Ratio
1827.99%277.66%162.67%13.95%17.49%2.06%
Buyback Yield / Dilution
0.17%0.51%0.71%-2.03%-9.33%-0.01%
Total Shareholder Return
11.56%8.03%1.86%0.13%-8.66%-0.01%